eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystoid macular dystrophy |
| Symptom | C0035328|retinal vein occlusion |
| Sentences | 122 |
| PubMedID- 22105941 | To investigate whether vitreous fluid levels of vascular endothelial growth factor (vegf), pigment epithelium-derived factor (pedf), and soluble intercellular adhesion molecule 1 (sicam-1) influence visual prognosis and macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 23225839 | Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion. |
| PubMedID- 21383939 | Clinical studies indicate that this dexamethasone implant is a promising new treatment option for patients with persistent macular edema resulting from retinal vein occlusion, diabetic retinopathy, and uveitis or irvine-gass syndrome. |
| PubMedID- 25902119 | Background: macular edema resulting from central retinal vein occlusion is effectively treated with anti-vascular endothelial growth factor injections. |
| PubMedID- 22481482 | Purpose: to investigate how combined cystoid spaces and serous retinal detachment affect photoreceptor status and visual acuity at final visit in macular edema associated with branch retinal vein occlusion. |
| PubMedID- 20681253 | We summarize the pathogenesis and the treatment strategy for macular edema in patients with branch retinal vein occlusion (brvo), focusing on the role of the cytokines. |
| PubMedID- 25644536 | Methods: we reviewed the medical records of 59 eyes with resolved macular edema associated with branch retinal vein occlusion. |
| PubMedID- 25960733 | The patient developed acute severe abdominal pain and nausea the day after ivb for retinal vein occlusion with macular edema, and massive lower gastrointestinal bleeding occurred. |
| PubMedID- 24332373 | Study population: thirteen eyes of 13 treatment-naive patients undergoing serial intravitreal anti-vascular endothelial growth factor (vegf) injections for exudative age-related macular degeneration or macular edema attributable to retinal vein occlusion. |
| PubMedID- 22080912 | Changes in visual acuity and foveal photoreceptor integrity in eyes with chronic cystoid macular edema associated with retinal vein occlusion. |
| PubMedID- 23539479 | Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion. |
| PubMedID- 23510041 | Background and objective: to evaluate the influence of serous retinal detachment (srd) on the outcome of pars plana vitrectomy (ppv) for macular edema in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 21744123 | Purpose: to report the formation of a lamellar macular hole (lmh) in four eyes with chronic cystoid macular edema (cme) associated with retinal vein occlusion (rvo). |
| PubMedID- 20182882 | Purpose: to compare visual outcomes after intravitreal triamcinolone acetonide (ivta) injection and intravitreal bevacizumab (ivb) administration for treatment of macular edema associated with branch retinal vein occlusion (brvo). |
| PubMedID- 25383828 | Results: initial ophthalmic examination showed bilateral central retinal vein occlusion with macular edema, including serous macular detachment in the left eye. |
| PubMedID- 25384627 | Photopic negative response in branch retinal vein occlusion with macular edema. |
| PubMedID- 25576994 | Therapies for macular edema associated with central retinal vein occlusion: a report by the american academy of ophthalmology. |
| PubMedID- 22991926 | Retinal function and morphology in central retinal vein occlusion with macular edema. |
| PubMedID- 25634982 | Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema. |
| PubMedID- 23044946 | Management of macular edema associated with retinal vein occlusion. |
| PubMedID- 22304619 | Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. |
| PubMedID- 24330936 | There is an urgent requirement to find effective therapeutic procedures for the treatment of refractory eye diseases of posterior segment such as posterior uveitis, proliferative vitreoretinopathy, and macular edema associated with diabetes and retinal vein occlusion. |
| PubMedID- 24439442 | Purpose: to determine whether a significant correlation exists between the presence of a bulge in the photoreceptor inner segment/outer segment (is/os) line and the best-corrected visual acuity (bcva) in eyes with resolved macular edema associated with branch retinal vein occlusion (brvo). |
| PubMedID- 24999721 | Methods: a retrospective review of six consecutive cases of central retinal vein occlusion with persistent macular edema despite regular anti-vascular endothelial growth factor injections that were transitioned to aflibercept was conducted. |
| PubMedID- 24884703 | Role of inflammation in previously untreated macular edema with branch retinal vein occlusion. |
| PubMedID- 21911591 | Purpose: to study the usefulness of focal macular electroretinography (fmerg) for evaluation of macular function in eyes with macular edema (me) associated with branch retinal vein occlusion (brvo). |
| PubMedID- 21845032 | In summary, the dex intravitreal implant is a minimally invasive treatment modality that has shown initial clinical efficacy in the treatment of macular edema resulting from retinal vein occlusion. |
| PubMedID- 21811207 | Three treatments for macular edema because of branch retinal vein occlusion: intravitreous bevacizumab or tissue plasminogen activator, and vitrectomy. |
| PubMedID- 21652108 | Efficacy of early injection of intravitreal triamcinolone acetonide (ivta) versus delayed injection for macular edema resulting from retinal vein occlusion. |
| PubMedID- 20827142 | Purpose: the purpose of this study was to evaluate the effect of intravitreal triamcinolone acetonide on macular function in cases of macular edema because of central retinal vein occlusion. |
| PubMedID- 24104718 | We report three patients of retinal vein occlusion with macular edema who demonstrated overnight resolution of macular edema following treatment with intravitreal ranibizumab (0.5 mg). |
| PubMedID- 23379834 | Background: it is unclear how retinal ischemia influences the changes of visual acuity, macular sensitivity, macular thickness, and macular volume after the performance of pars plana vitrectomy (ppv) for macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 24447389 | Additional sources of data included clinical study reports for ranibizumab , the dexamethasone ivt manufacturer’s submission to the national institute for health and clinical excellence (nice) for dexamethasone ivt and the evidence review group response and results of the global evaluation of implantable dexamethasone in retinal vein occlusion with macular edema (geneva) studies reported within the clinicaltrials.gov records . |
| PubMedID- 26501219 | The primary treatment against macular edema with retinal vein occlusion (rvo) has changed from observation in central rvo (crvo) and laser photocoagulation in branch rvo (brvo) to administration of intravitreal agents based on anti-vascular endothelial growth factor (vegf) or anti-inflammatory strategies. |
| PubMedID- 22140307 | This study led to fda approval of the dexamethasone implant for the treatment of macular edema associated with retinal vein occlusion. |
| PubMedID- 22183139 | Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab. |
| PubMedID- 24894397 | Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema. |
| PubMedID- 25371814 | Long-term outcome after vitrectomy for macular edema with retinal vein occlusion dividing into the occlusion site. |
| PubMedID- 25657578 | Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion. |
| PubMedID- 21538003 | Purpose: to investigate the correlation of soluble intercellular adhesion molecule 1 (sicam-1) and vascular endothelial growth factor (vegf) with macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 21275514 | Purpose: to investigate whether pigment epithelium-derived factor (pedf) or vascular endothelial growth factor (vegf) influences macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 22653545 | Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. |
| PubMedID- 24528934 | Purpose: to test a combination of dexamethasone intravitreal implant with macular grid laser for macular edema in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 21726846 | Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion. |
| PubMedID- 24084497 | Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 galileo study. |
| PubMedID- 23842103 | Purpose: to evaluate the association between vitreous fluid levels of inflammatory factors and macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 21494891 | Introduction: the ozurdex((r)) (allergan inc., irvine, ca, usa) dexamethasone drug delivery system (dds) was recently developed as a biodegradable intravitreal implant to provide sustained delivery of 700 mug of preservativefree dexamethasone to the retina and vitreous, and is approved by the united states food and drug administration (fda) for the treatment of macular edema associated with retinal vein occlusion, as well as for noninfectious posterior uveitis. |
| PubMedID- 23411880 | Objective: to evaluate the association between vitreous fluid levels of inflammatory factors and macular edema in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 26335912 | Purpose: our aim was to investigate predictive factors associated with efficacy and recurrence after intravitreal bevacizumab (ivb) therapy for macular edema (me) in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 20429890 | These results suggest that the vitreous level of vascular endothelial growth factor might influence the visual prognosis and the response of macular edema to vitrectomy in patients with branch retinal vein occlusion. |